Position
Caption Management, LLC in Arcus Biosciences, Inc.
Back to the book · All holders of RCUS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$35.8K$23.83 → $21.60
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 767.7K | $18.3M | — | — | — | 0.1% |
| Q1 2026 | 16K | $346.3K | $21.60 | −$35.8K | −$17.9M | 0.0% |